US equities
|
NVDA
$125.53
▼-14.01%
ANT
$88.91
▼-8.50%
MU
$594.51
▼-13.89%
AMD
$424.39
▼-13.25%
AAPL
$342.56
▼-1.90%
MSFT
$484.52
▼-2.77%
AMZN
$246.82
▼-4.10%
AVGO
$304.41
▼-12.19%
NVDA
$125.53
▼-14.01%
ANT
$88.91
▼-8.50%
MU
$594.51
▼-13.89%
AMD
$424.39
▼-13.25%
AAPL
$342.56
▼-1.90%
MSFT
$484.52
▼-2.77%
AMZN
$246.82
▼-4.10%
AVGO
$304.41
▼-12.19%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Kidney Diseases
Recent news which mentions Kidney Diseases
MorphoSys Presents Early Felzartamab Data From Autoimmune Kidney Disease Trial
November 05, 2021
Tickers
IMAB
MOR
Tags
Rare Kidney Diseases
Movers
Phase 1 Trial
From
Benzinga
Novartis' Iptacopan Meets Primary Endpoint Goal In Rare Kidney Disease Trial
November 04, 2021
Tickers
NVS
Tags
Health Care
News
NVS
From
Benzinga
Dicerna Posts Mixed Nedosiran Data In Rare Kidney Disease Trial
October 19, 2021
Tickers
DRNA
Tags
Movers
Kidney Diseases
Trading Ideas
From
Benzinga